Filing Flows › Vycor Medical (VYCO) › Q2 2026 › vs Q1 2026
Vycor Medical (VYCO) Q2 2026 vs Q1 2026 (quarter over quarter)
Vycor Medical's revenue fell $40K (-9%) from $459K in Q1 2026 to $418K in Q2 2026. The biggest changes: Vycor Medical Inc −$39K (-9%); NovaVision Inc −$1K (-6%).
Vycor Medical, Q2 2026: revenue $418K (-16% year over year), operating margin 1.6%, net loss $22K, operating cash flow −$5K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Vycor Medical Inc | $401K | $440K | −$39K | -9% |
| NovaVision Inc | $17K | $18K | −$1K | -6% |
| Revenue | $418K | $459K | −$40K | -9% |
| Net loss | $22K | −$20K | $42K | — |
| Costs & expenses | $441K | $459K | −$18K | -4% |
| Operating costs | $411K | $413K | −$1K | -0.3% |
| Interest & other, net | $26K | $26K | $247 | +1% |
| Income tax | $3K | −$13 | $3K | — |
| Cost of revenue | $74K | $83K | −$10K | -11% |
| SG&A | $323K | $315K | $7K | +2% |
| Other operating costs | $15K | $14K | $1K | +6% |
| Operating cash sources | $22K | −$20K | $42K | — |
| Depreciation & amortization | $15K | $14K | $1K | +6% |
| Working capital & other | $3K | $65K | −$63K | -96% |
| Cash used in operations | $5K | −$99K | $104K | — |
| Net loss absorbed | $22K | −$20K | $42K | — |
Questions
How much did Vycor Medical's revenue grow quarter over quarter in Q2 2026?
Vycor Medical's revenue fell $40K (-9%) from $459K in Q1 2026 to $418K in Q2 2026.
What drove Vycor Medical's revenue change in Q2 2026?
Vycor Medical Inc −$39K (-9%); NovaVision Inc −$1K (-6%).